Hansoh Pharma, a leading innovation-driven pharmaceutical company in the PRC, is committed to improving human health through unremitting innovation, focusing mainly on such areas as anti-tumor, anti-infectives, CNS diseases, metabolic diseases, autoimmune diseases.
After more than 20 years of continuous investment in R&D, Hansoh Pharma has marketed 7 innovative drugs and has over 30 innovative drug programs in different clinical stages with over 50 clinical trials in progress, forming a rich pipeline.
Find the latest and most complete information about Hansoh Pharma!
Hansoh Pharma has always focused on corporate governance, corporate behavior, product safety and quality, access to healthcare, human resource development, environmental protection and community enhancement as the focus and the basis of ESG management, and has been continually committed to improving the medicine availability and the innovative development in fields with unmet clinical needs.
We welcome talents worldwide to join us with their entrepreneurship and achieve new levels of success in their career!
9月8日下午,市委副书记、组织部长万闻华一行到豪森调研,市委常委、开发区党工委书记关永健等领导陪同调研。集团总裁吕爱锋接待了万书记一行。
万书记先后调研了集团展厅和研究院,深入了解豪森的发展历程、科技创新水平和成果,人才建设成果,以及党工建设情况。在了解到豪森从仿制到创新的战略部署,多点布局国际化战略,第一个原创新药已于2014年上市等情况后,万书记对今日豪森的发展成就给予了肯定和高度评价。